Researchers indicated that while current vaccines for SARS-CoV-2 and influenza are generally safe and effective, there is still considerable room for improvement.

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

More research is needed to understand the rise in type 1 diabetes diagnoses since the beginning of the pandemic. The COVID-19 ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

As highly pathogenic H5N1 avian influenza continues to spread in the U.S., posing serious threats to dairy and poultry farms, ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations ...

Cornell University researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu ...

SARS-CoV-2 secondary structure shapes mutation frequencies, constraining viral evolution models predicting fitness can benefit from integrating secondary structure data.

HKU5-CoV-2 is a form of coronavirus that was just detected in bats. The recent study picked up the virus after analyzing anal ...

Researchers found that lesions in patients with SARS-CoV-2 infection demonstrated more rapid progression of overall percent atheroma volume (PAV) and noncalcified PAV compared with lesions in patients ...

A new coronavirus lineage discovered in bats by Wuhan scientists can infect human cells but is not a current public health threat, experts say ...